Adaptive Biotechnologies: Q1 Earnings Snapshot

Published: 2026-05-05 17:02:16 ET ADPT

Published on 05/05/2026 at 05:02 pm EDT

SEATTLE (AP) — SEATTLE (AP) — Adaptive Biotechnologies Corp. (ADPT) on Tuesday reported a loss of $20 million in its first quarter.

The Seattle-based company said it had a loss of 13 cents per share.

The results beat Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 16 cents per share.

The life-sciences research company posted revenue of $70.9 million in the period, also exceeding Street forecasts. Five analysts surveyed by Zacks expected $61.8 million.

Adaptive Biotechnologies shares have dropped 15% since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $13.80, a rise of 38% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ADPT at https://www.zacks.com/ap/ADPT

For copyright information, check with the distributor of this item, STATS Perform dba Automated Insights. , source Associated Press News